|
Volumn 26, Issue 8, 2008, Pages 1387-1388
|
Long overdue: Phase II studies in older cancer patients: Where does the FDA stand?
a b b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
UFT;
ANTINEOPLASTIC AGENT;
CANCER PATIENT;
CANCER RESEARCH;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LETTER;
MALIGNANT NEOPLASTIC DISEASE;
PRIORITY JOURNAL;
AGE DISTRIBUTION;
AGED;
COLORECTAL TUMOR;
GERIATRIC ASSESSMENT;
GERIATRICS;
NOTE;
ONCOLOGY;
PATHOLOGY;
UNITED STATES;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
COLORECTAL NEOPLASMS;
DRUG APPROVAL;
GERIATRIC ASSESSMENT;
GERIATRICS;
HUMANS;
MEDICAL ONCOLOGY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 41649089531
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2007.15.7677 Document Type: Letter |
Times cited : (4)
|
References (6)
|